SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ProMetic Life Sciences

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cush who wrote (143)11/17/2017 5:55:00 AM
From: axial   of 250
 
' RDR: How is Ryplazim administered?

Laurin: It is an infusion that initially will be given by a health professional but after 2 or 3 infusions we know that patients or their caregivers can usually administer the product at home. There will be home infusion centers for those who prefer that approach.

The frequency of the administration will depend on the patient and their condition. For acute care to remove lesions, infusions every 3 or 4 days will be likely but once the lesions are out, the maintenance treatment needed to prevent lesions from coming back will vary from patient to patient—maybe every second or third week.'

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext